Procter & Gamble (NYSE:PG - Get Free Report) had its price objective lifted by equities researchers at TD Cowen from $166.00 to $180.00 in a report issued on Friday, Benzinga reports. The firm currently has a "hold" rating on the stock. TD Cowen's price target points to a potential upside of 5.37% from the stock's previous close.
PG has been the topic of several other research reports. Barclays lifted their target price on shares of Procter & Gamble from $152.00 to $165.00 and gave the stock an "equal weight" rating in a research note on Monday, October 26th. Deutsche Bank reiterated a "buy" rating on shares of Procter & Gamble in a research report on Friday, October 23rd. Sanford C. Bernstein reissued a "market perform" rating and issued a $149.00 price target on shares of Procter & Gamble in a research note on Monday, August 24th. Wells Fargo & Company boosted their price target on shares of Procter & Gamble from $180.00 to $188.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, UBS Group set a $166.00 price target on shares of Procter & Gamble in a research report on Friday, October 23rd. Fifteen research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $171.62.
Read Our Latest Research Report on PG
Procter & Gamble Stock Performance
NYSE PG opened at $170.83 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. The stock's 50 day simple moving average is $156.37 and its 200-day simple moving average is $150.33. The company has a market cap of $395.94 billion, a PE ratio of 25.70, a price-to-earnings-growth ratio of 4.19 and a beta of 0.36. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $173.59.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The firm had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. During the same period in the previous year, the business earned $1.99 earnings per share. The firm's revenue for the quarter was up 4.0% on a year-over-year basis. As a group, equities research analysts anticipate that Procter & Gamble will post 6.99 EPS for the current fiscal year.
Insider Activity
In related news, CFO Andre Schulten sold 33,624 shares of the company's stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $165.00, for a total value of $5,547,960.00. Following the completion of the sale, the chief financial officer owned 65,618 shares of the company's stock, valued at approximately $10,826,970. This represents a 33.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Shailesh Jejurikar sold 35,000 shares of the company's stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $163.09, for a total transaction of $5,708,150.00. Following the completion of the sale, the chief executive officer directly owned 55,391 shares of the company's stock, valued at $9,033,718.19. This represents a 38.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 193,738 shares of company stock worth $31,813,782. Insiders own 0.23% of the company's stock.
Institutional Trading of Procter & Gamble
Institutional investors have recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Procter & Gamble during the second quarter worth $27,862,105,000. State Street Corp grew its holdings in shares of Procter & Gamble by 0.8% during the 3rd quarter. State Street Corp now owns 103,054,240 shares of the company's stock worth $14,971,720,000 after purchasing an additional 837,932 shares during the period. Bank of America Corp DE purchased a new position in shares of Procter & Gamble during the 2nd quarter worth $3,850,628,000. Bank of New York Mellon Corp acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth about $2,281,505,000. Finally, Fisher Asset Management LLC increased its position in shares of Procter & Gamble by 7.5% during the 3rd quarter. Fisher Asset Management LLC now owns 12,084,656 shares of the company's stock worth $1,755,659,000 after purchasing an additional 845,717 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Key Headlines Impacting Procter & Gamble
Investors following PG have been watching these headlines:
- Positive Sentiment: P&G is targeting up to $10 billion in productivity savings by 2030, with automation and other efficiency measures. The cost-reduction goal is a potential boost to margins and helped support investor sentiment after Investor Day. Benzinga article
- Positive Sentiment: The company reaffirmed its fiscal 2027 outlook, providing some stability on expectations. P&G also said its latest quarterly payout marked its 70th consecutive year of dividend increases. RTTNews article Dividend article
- Negative Sentiment: The savings plan includes a 20%–30% reduction in product-supply roles, including contractors, by 2030. While intended to improve efficiency, execution and workforce-disruption risks remain; reports also point to a tougher earnings-growth environment. Wall Street Journal article
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.